FR2514003A1 - Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine - Google Patents

Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine Download PDF

Info

Publication number
FR2514003A1
FR2514003A1 FR8216580A FR8216580A FR2514003A1 FR 2514003 A1 FR2514003 A1 FR 2514003A1 FR 8216580 A FR8216580 A FR 8216580A FR 8216580 A FR8216580 A FR 8216580A FR 2514003 A1 FR2514003 A1 FR 2514003A1
Authority
FR
France
Prior art keywords
ita
obtaining
pharmacological activity
activity
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8216580A
Other languages
English (en)
French (fr)
Inventor
Jose Miguel B Ribalta
Leonida Bruseghini
Silvano Casadio
Jorge D Adsara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigacion Tecnica y Aplicada SA
Original Assignee
Investigacion Tecnica y Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigacion Tecnica y Aplicada SA filed Critical Investigacion Tecnica y Aplicada SA
Publication of FR2514003A1 publication Critical patent/FR2514003A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8216580A 1981-10-06 1982-09-30 Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine Withdrawn FR2514003A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES506046A ES8303412A1 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Publications (1)

Publication Number Publication Date
FR2514003A1 true FR2514003A1 (fr) 1983-04-08

Family

ID=8483044

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8216580A Withdrawn FR2514003A1 (fr) 1981-10-06 1982-09-30 Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine

Country Status (7)

Country Link
JP (1) JPS5872584A (es)
BE (1) BE894597A (es)
DE (1) DE3237064A1 (es)
ES (1) ES8303412A1 (es)
FR (1) FR2514003A1 (es)
GB (1) GB2107709A (es)
IT (1) IT1191214B (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103497A1 (fr) * 1982-07-28 1984-03-21 Adir Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0590919A1 (en) * 1992-09-28 1994-04-06 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agents for parkinson's disease
FR2812290A1 (fr) * 2000-07-28 2002-02-01 Ing Jun Chen Derives n-3,7 substitues de 1-methylxantine presentant des activites inhibitrices sur les phosphodiesterases de type cinq

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710572A (en) * 1986-07-30 1987-12-01 American Home Products Corporation Histamine H1 antagonists
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
GB0009479D0 (en) * 2000-04-17 2000-06-07 Cipla Limited Antihistaminic compounds
EP2159226B1 (de) * 2007-03-29 2016-08-31 Joint-stock Company "Obninsk Chemical Pharmaceutical Company" Antihistamin- und antiallergienmittel sowie verfahren zu seiner herstellung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5086M (es) * 1964-12-08 1967-05-16
FR2489331A1 (fr) * 1980-09-04 1982-03-05 Eisai Co Ltd Derives de la theophylline et de la theobromine, leurs procedes de preparation et composition therapeutique les contenant
EP0087810A1 (en) * 1982-03-02 1983-09-07 Eisai Co., Ltd. Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5086M (es) * 1964-12-08 1967-05-16
FR2489331A1 (fr) * 1980-09-04 1982-03-05 Eisai Co Ltd Derives de la theophylline et de la theobromine, leurs procedes de preparation et composition therapeutique les contenant
EP0087810A1 (en) * 1982-03-02 1983-09-07 Eisai Co., Ltd. Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103497A1 (fr) * 1982-07-28 1984-03-21 Adir Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0590919A1 (en) * 1992-09-28 1994-04-06 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agents for parkinson's disease
FR2812290A1 (fr) * 2000-07-28 2002-02-01 Ing Jun Chen Derives n-3,7 substitues de 1-methylxantine presentant des activites inhibitrices sur les phosphodiesterases de type cinq

Also Published As

Publication number Publication date
ES506046A0 (es) 1983-02-01
BE894597A (fr) 1983-01-31
DE3237064A1 (de) 1983-04-21
ES8303412A1 (es) 1983-02-01
JPS5872584A (ja) 1983-04-30
IT1191214B (it) 1988-02-24
GB2107709A (en) 1983-05-05
IT8268159A0 (it) 1982-10-01

Similar Documents

Publication Publication Date Title
EP0506532B1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
EP0103497B1 (fr) Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
CH639070A5 (fr) 4-(di-n-propyl)amino-1,3,4,5-tetrahydrobenzo(cd)indole et composition pharmaceutique en contenant.
CH644348A5 (fr) Amino-ethers oxydes, leur procede de preparation et medicament les contenant.
FR2476088A2 (fr) Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique
FR2465732A1 (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique
FR2493315A1 (fr) Derive de piperazine, procede pour sa preparation et composition analgesique en contenant
EP0148167B1 (fr) Nouveaux dérivés de la quinoléine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
FR2623808A1 (fr) Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP0360685A1 (fr) "[(diarylméthoxy) alcoyl] - 1 pyrrolidines et piperidines, procédés de préparation et médicaments les contenant"
EP0301936B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
EP0021924B1 (fr) Dérivés de l'indole, procédé pour leur préparation, leur application comme médicaments et compositions pharmaceutiques les contenant
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
EP0385848A1 (fr) Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
DK159435B (da) Analogifremgangsmaade til fremstilling af 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesyrederivater eller et farmaceutisk acceptabelt syreadditionssalt deraf
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
CH650254A5 (fr) Quinolones, leurs procedes de preparation et compositions therapeutiques les contenant.
FR2669633A1 (fr) Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0196943B1 (fr) Nouveaux dérivés 8-thiotétrahydroquinoléines et leurs sels
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
CH652119A5 (fr) Derives de l'acide guanidinocyclohexanecarboxylique et leur procede de fabrication.
EP0362006A1 (fr) Dérivés de quinoléine, leurs procédés de préparation et les médicaments les contenant
FR2519982A1 (fr) Nouveaux derives de l'indoline, leur preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse